Sueck F, Specht J, Cramer B, Humpf HU (2020) Identification of ochratoxin-N-acetyl-L-cysteine as a new ochratoxin A metabolite and potential biomarker in human urine
PRECAUTIONS: Caution should be taken with those with kidney disorders or problems hyperuricemia
Egrifta WR cuts injection prep down to once per week instead of daily
These are based largely on expert opinion and multi-society consensus, which may lead to variations in clinical practice both regionally and globally
Thornburgh, S., & Gaskins, A
The experience of tiredness can vary considerably between individualssome may notice mild lethargy during the initial weeks of treatment, whilst others may experience more persistent symptoms that affect daily functioning